000			02290nam a2200469 i 4500
001			ocn954782684
003			OCoLC
005			20160914054544.0
006			m o d f
007			cr bn||||m||||
008			160804s2016 dcua ob f000 0 eng c
040			_aGPO _beng _erda _epn _cGPO _dGPO
042			_apcc
043			_an-us---
050	1	4	_aKF27 _b.V462 2015c
074			_a1027-C (online)
086	0		_aY 4.V 64/3:114-25
088			_aSerial no. 114-25 (United States. Congress. House. Committee on Veterans' Affairs)
099			_aY 4.V 64/3:114-25
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Veterans' Affairs. _bSubcommittee on Oversight and Investigations, _eauthor.
245	1	0	_aPrescription mismanagement and the risk of veteran suicide : _bhearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Fourteenth Congress, first session, Wednesday, June 10, 2015.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2016.
300			_a1 online resource (iii, 74 pages) : _billustration
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_aTitle from title screen (viewed on Aug. 4, 2016).
500			_aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
504			_aIncludes bibliographical references.
500			_a"Serial no. 114-25."
500			_aCRDP Project record.
650		0	_aDrugs _xPrescribing _zUnited States.
650		0	_aMedication abuse _zUnited States.
650		0	_aVeterans _xSuicidal behavior _zUnited States.
650		0	_aSuicide _xRisk factors _zUnited States.
650		0	_aVeterans _xMental health _zUnited States.
650		0	_aAntidepressants _zUnited States.
610	1	0	_aUnited States. _bDepartment of Veterans Affairs _xRules and practice _xEvaluation.
655		7	_aLegislative hearings. _2lcgft
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations. _tPrescription mismanagement and the risk of veteran suicide _w(OCoLC)955323861
856	4	0	_uhttp://purl.fdlp.gov/GPO/gpo70836
999			_c254338 _d254338